NCT03955484 - Benign Prostatic Hyperplasia and Glycosaminoglycan | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

September 1, 2019

Study Completion Date

November 1, 2019

Conditions

Prostatic Hyperplasia

Interventions

DIAGNOSTIC_TEST

Urinary Glycosaminoglycan

Urine will be collected from patients before and after one month of medical treatment (alpha-blocker). After being centrifuged at 5000 g for 10 minutes, urine will be stored at -80 ° C. At the end of the study, urinary glycosaminoglycan levels will be studied by spectrophotometric method.

Trial Locations (1)

34000

RECRUITING

Marmara University, Istanbul